503 related articles for article (PubMed ID: 21389984)
1. Caspase signalling controls microglia activation and neurotoxicity.
Burguillos MA; Deierborg T; Kavanagh E; Persson A; Hajji N; Garcia-Quintanilla A; Cano J; Brundin P; Englund E; Venero JL; Joseph B
Nature; 2011 Apr; 472(7343):319-24. PubMed ID: 21389984
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
3. Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
Afeseh Ngwa H; Kanthasamy A; Anantharam V; Song C; Witte T; Houk R; Kanthasamy AG
Toxicol Appl Pharmacol; 2009 Oct; 240(2):273-85. PubMed ID: 19646462
[TBL] [Abstract][Full Text] [Related]
4. The executioners sing a new song: killer caspases activate microglia.
Venero JL; Burguillos MA; Brundin P; Joseph B
Cell Death Differ; 2011 Nov; 18(11):1679-91. PubMed ID: 21836616
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism.
Viceconte N; Burguillos MA; Herrera AJ; De Pablos RM; Joseph B; Venero JL
J Neuroinflammation; 2015 Jan; 12():5. PubMed ID: 25586882
[TBL] [Abstract][Full Text] [Related]
6. Plasmalogens Inhibit Endocytosis of Toll-like Receptor 4 to Attenuate the Inflammatory Signal in Microglial Cells.
Ali F; Hossain MS; Sejimo S; Akashi K
Mol Neurobiol; 2019 May; 56(5):3404-3419. PubMed ID: 30128650
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.
Taylor DL; Jones F; Kubota ES; Pocock JM
J Neurosci; 2005 Mar; 25(11):2952-64. PubMed ID: 15772355
[TBL] [Abstract][Full Text] [Related]
8. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration.
Wang X; Chen S; Ma G; Ye M; Lu G
Mech Ageing Dev; 2005 Dec; 126(12):1241-54. PubMed ID: 16112714
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
[TBL] [Abstract][Full Text] [Related]
10. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.
Hartmann A; Hunot S; Michel PP; Muriel MP; Vyas S; Faucheux BA; Mouatt-Prigent A; Turmel H; Srinivasan A; Ruberg M; Evan GI; Agid Y; Hirsch EC
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2875-80. PubMed ID: 10688892
[TBL] [Abstract][Full Text] [Related]
11. Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway:
Cai QY; Liu XL; Zhang XQ; Liu YX; Li M; Zhao CZ; Zhang XM; Meng QH
Pharmazie; 2016 Oct; 71(10):575-582. PubMed ID: 29441925
[TBL] [Abstract][Full Text] [Related]
12. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration.
Kaul S; Kanthasamy A; Kitazawa M; Anantharam V; Kanthasamy AG
Eur J Neurosci; 2003 Sep; 18(6):1387-401. PubMed ID: 14511319
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta.
Hanrott K; Gudmunsen L; O'Neill MJ; Wonnacott S
J Biol Chem; 2006 Mar; 281(9):5373-82. PubMed ID: 16361258
[TBL] [Abstract][Full Text] [Related]
14. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.
Peng GS; Li G; Tzeng NS; Chen PS; Chuang DM; Hsu YD; Yang S; Hong JS
Brain Res Mol Brain Res; 2005 Mar; 134(1):162-9. PubMed ID: 15790540
[TBL] [Abstract][Full Text] [Related]
15. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Furuya T; Hayakawa H; Yamada M; Yoshimi K; Hisahara S; Miura M; Mizuno Y; Mochizuki H
J Neurosci; 2004 Feb; 24(8):1865-72. PubMed ID: 14985426
[TBL] [Abstract][Full Text] [Related]
16. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
17. Ferulic Acid Rescues LPS-Induced Neurotoxicity via Modulation of the TLR4 Receptor in the Mouse Hippocampus.
Rehman SU; Ali T; Alam SI; Ullah R; Zeb A; Lee KW; Rutten BPF; Kim MO
Mol Neurobiol; 2019 Apr; 56(4):2774-2790. PubMed ID: 30058023
[TBL] [Abstract][Full Text] [Related]
18. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
Gao HM; Jiang J; Wilson B; Zhang W; Hong JS; Liu B
J Neurochem; 2002 Jun; 81(6):1285-97. PubMed ID: 12068076
[TBL] [Abstract][Full Text] [Related]
19. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.
Pabon MM; Bachstetter AD; Hudson CE; Gemma C; Bickford PC
J Neuroinflammation; 2011 Jan; 8():9. PubMed ID: 21266082
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines in inflammatory process in Parkinson's disease.
Sawada M; Imamura K; Nagatsu T
J Neural Transm Suppl; 2006; (70):373-81. PubMed ID: 17017556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
